Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 3/2012

Open Access 01-06-2012 | Research

Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children

Authors: XiWang Liu, QiXing Chen, ShanShan Shi, Zhuo Shi, Ru Lin, LinHua Tan, JianGen Yu, Qiang Shu, XiangMing Fang

Published in: Critical Care | Issue 3/2012

Login to get access

Abstract

Introduction

Acute lung injury (ALI) after cardiac surgery is associated with a high postoperative morbidity and mortality, but few predictors are known for the occurrence of the complication. This study evaluated whether elevated plasma levels of soluble receptor for advanced glycation end products (sRAGE) and S100A12 reflected impaired lung function in infants and young children after cardiac surgery necessitating cardiopulmonary bypass (CPB).

Methods

Consecutive children younger than 3 years after cardiac surgery were prospectively enrolled and assigned to ALI and non-ALI groups, according to the American-European Consensus Criteria. Plasma concentrations of sRAGE and S100A12 were measured at baseline, before, and immediately after CPB, as well as 1 hour, 12 hours, and 24 hours after operation.

Results

Fifty-eight patients were enrolled and 16 (27.6%) developed postoperative ALI. Plasma sRAGE and S100A12 levels increased immediately after CPB and remained significantly higher in the ALI group even 24 hour after operation (P < 0.01). In addition, a one-way MANOVA revealed that the overall sRAGE and S100A12 levels were higher in the ALI group than in the non-ALI group immediately after CPB (P < 0.001). The multivariate logistic regression analysis showed that the plasma sRAGE level immediately after CPB was an independent predictor for postoperative ALI (OR, 1.088; 95% CI, 1.011 to 1.171; P = 0.025). Increased sRAGE and S100A12 levels immediately after CPB were significantly correlated with a lower PaO2/FiO2 ratio (P < 0.01) and higher radiographic lung-injury score (P < 0.01), as well as longer mechanical ventilation time (sRAGEN: r = 0.405; P = 0.002; S100A12N: r = 0.322; P = 0.014), longer surgical intensive care unit stay (sRAGEN: r = 0.421; P = 0.001; S100A12N: r = 0.365; P = 0.005) and hospital stay (sRAGEN: r = 0.329; P = 0.012; S100A12N: r = 0.471; P = 0.001).

Conclusions

Elevated sRAGE and S100A12 levels correlate with impaired lung function, and sRAGE is a useful early biomarker of ALI in infants and young children undergoing cardiac surgery.
Appendix
Available only for authorised users
Literature
1.
Apostolakis E, Filos KS, Koletsis E, Dougenis D: Lung dysfunction following cardiopulmonary bypass. J Card Surg 2010, 25: 47-55. 10.1111/j.1540-8191.2009.00823.xCrossRefPubMed
2.
Milot J, Perron J, Lacasse Y, Létourneau L, Cartier PC, Maltais F: Incidence and predictors of ARDS after cardiac surgery. Chest 2001, 119: 884-888. 10.1378/chest.119.3.884CrossRefPubMed
3.
Verheij J, van Lingen A, Raijmakers PG, Spijkstra JJ, Girbes AR, Jansen EK, van den Berg FG, Groeneveld AB: Pulmonary abnormalities after cardiac surgery are better explained by atelectasis than by increased permeability oedema. Acta Anaesthesiol Scand 2005, 49: 1302-1310. 10.1111/j.1399-6576.2005.00831.xCrossRefPubMed
4.
Raijmakers PG, Groeneveld AB, Schneider AJ, Teule GJ, van Lingen A, Eijsman L, Thijs LG: Transvascular transport of 67Ga in the lungs after cardiopulmonary bypass surgery. Chest 1993, 104: 1825-1832. 10.1378/chest.104.6.1825CrossRefPubMed
5.
Clark SC: Lung injury after cardiopulmonary bypass. Perfusion 2006, 21: 225-228. 10.1191/0267659106pf872oaCrossRefPubMed
6.
Santos AR, Heidemann SM, Walters HL, Delius RE: Effect of inhaled corticosteroid on pulmonary injury and inflammatory mediator production after cardiopulmonary bypass in children. Pediatr Crit Care Med 2007, 8: 465-469. 10.1097/01.PCC.0000282169.11809.80CrossRefPubMed
7.
Komai H, Naito Y, Okamura Y: Dextran sulfate as a leukocyte-endothelium adhesion molecule inhibitor of lung injury in pediatric open-heart surgery. Perfusion 2005, 20: 77-82. 10.1191/0267659105pf788oaCrossRefPubMed
8.
Shi S, Zhao Z, Liu X, Shu Q, Tan L, Lin R, Shi Z, Fang X: Perioperative risk factors for prolonged mechanical ventilation following cardiac surgery in neonates and young infants. Chest 2008, 134: 768-774. 10.1378/chest.07-2573CrossRefPubMed
9.
Creagh-Brown BC, Quinlan GJ, Evans TW, Burke-Gaffney A: The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target? Intensive Care Med 2010, 36: 1644-1656. 10.1007/s00134-010-1952-zCrossRefPubMed
10.
Schmidt AM, Yan SD, Yan SF, Stern DM: The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001, 108: 949-955.PubMedCentralCrossRefPubMed
11.
Shirasawa M, Fujiwara N, Hirabayashi S, Ohno H, Iida J, Makita K, Hata Y: Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 2004, 9: 165-174. 10.1111/j.1356-9597.2004.00712.xCrossRefPubMed
12.
13.
Jabaudon M, Futier E, Roszyk L, Chalus E, Guerin R, Petit A, Mrozek S, Perbet S, Cayot-Constantin S, Chartier C, Sapin V, Bazin JE, Constantin JM: Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med 2011, 39: 480-488. 10.1097/CCM.0b013e318206b3caCrossRefPubMed
14.
Wittkowski H, Sturrock A, van Zoelen MA, Viemann D, van der Poll T, Hoidal JR, Roth J, Foell D: Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 2007, 35: 1369-1375. 10.1097/01.CCM.0000262386.32287.29CrossRefPubMed
15.
Mauri T, Masson S, Pradella A, Bellani G, Coppadoro A, Bombino M, Valentino S, Patroniti N, Mantovani A, Pesenti A, Latini R: Elevated plasma and alveolar levels of soluble receptor for advanced glycation endproducts are associated with severity of lung dysfunction in ARDS patients. Tohoku J Exp Med 2010, 222: 105-112. 10.1620/tjem.222.105CrossRefPubMed
16.
Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA, the NHLBI ARDS Network: Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008, 63: 1083-1089. 10.1136/thx.2008.095588PubMedCentralCrossRefPubMed
17.
Pietzsch J, Hoppmann S: Human S100A12: a novel key player in inflammation? Amino Acids 2009, 36: 381-389. 10.1007/s00726-008-0097-7CrossRefPubMed
18.
Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97: 889-901. 10.1016/S0092-8674(00)80801-6CrossRefPubMed
19.
Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, Plachky J, Gröne HJ, Kurschus FC, Schmidt AM, Yan SD, Martin E, Schleicher E, Stern DM, Hämmerling G G, Nawroth PP, Arnold B: Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004, 113: 1641-1650.PubMedCentralCrossRefPubMed
20.
Agostoni P, Banfi C, Brioschi M, Magrì D, Sciomer S, Berna G, Brambillasca C, Marenzi G, Sisillo E: Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: a pilot study. Eur Respir J 2011, 37: 841-847. 10.1183/09031936.00045910CrossRefPubMed
21.
Kikkawa T, Sato N, Kojika M, Takahashi G, Aoki K, Hoshikawa K, Akitomi S, Shozushima T, Suzuki K, Wakabayashi G, Endo S: Significance of measuring S100A12 and sRAGE in the serum of sepsis patients with postoperative acute lung injury. Dig Surg 2010, 27: 307-312. 10.1159/000313687CrossRefPubMed
22.
Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988, 138: 720-723.CrossRefPubMed
23.
Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149: 818-824.CrossRefPubMed
24.
Kim JK, Park S, Lee MJ, Song YR, Han SH, Kim SG, Kang SW, Choi KH, Kim HJ, Yoo TH: Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis 2012, 20: 208-214.CrossRef
25.
Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E, Büchler MW, Weigand MA: sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008, 147: 79-83. 10.1016/j.jss.2007.07.014CrossRefPubMed
26.
Lizotte PP, Hanford LE, Enghild JJ, Nozik-Grayck E, Giles BL, Oury TD: Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev Biol 2007, 7: 15. 10.1186/1471-213X-7-15PubMedCentralCrossRefPubMed
27.
Sukkar MB, Wood LG, Tooze M, Simpson JL, McDonald VM, Gibson PG, Wark PA: Soluble RAGE is deficient in neutrophilic asthma and chronic obstructive pulmonary disease. Eur Respir J 2012, 39: 721-729. 10.1183/09031936.00022011CrossRefPubMed
28.
Kumano-Kuramochi M, Ohnishi-Kameyama M, Xie Q, Niimi S, Kubota F, Komba S, Machida S: Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability. Biochem Biophys Res Commun 2009, 386: 130-134. 10.1016/j.bbrc.2009.05.142CrossRefPubMed
29.
30.
Goodman RB, Pugin J, Lee JS, Matthay MA: Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003, 14: 523-535. 10.1016/S1359-6101(03)00059-5CrossRefPubMed
31.
Massoudy P, Zahler S, Becker BF, Braun SL, Barankay A, Meisner H: Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest 2001, 119: 31-36. 10.1378/chest.119.1.31CrossRefPubMed
32.
Mauri T, Coppadoro A, Bellani G, Bombino M, Patroniti N, Peri G, Mantovani A, Pesenti A: Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity. Crit Care Med 2008, 36: 2302-2308. 10.1097/CCM.0b013e3181809aafCrossRefPubMed
33.
Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner KT, Nawroth PP: The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003, 198: 1507-1515. 10.1084/jem.20030800PubMedCentralCrossRefPubMed
34.
Adembri C, Kastamoniti E, Bertolozzi I, Vanni S, Dorigo W, Coppo M, Pratesi C, De Gaudio AR, Gensini GF, Modesti PA: Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery. Crit Care Med 2004, 32: 1170-1177. 10.1097/01.CCM.0000124875.98492.11CrossRefPubMed
35.
Worrall NK, Chang K, LeJeune WS, Misko TP, Sullivan PM, Ferguson TB Jr, Williamson JR: TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol 1997, 273: H2565-H2574.PubMed
36.
Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat M, Zhao JH, Ramasamy A, Zhai G, Vitart V, Huffman JE, Igl W, Albrecht E, Deloukas P, Henderson J, Granell R, McArdle WL, Rudnicka AR, Wellcome Trust Case Control Consortium, Barroso I, Loos RJ, Wareham NJ, Mustelin L, Rantanen T, Surakka I, Imboden M, Wichmann HE, Grkovic I, Jankovic S, Zgaga L, et al.: Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010, 42: 36-44. 10.1038/ng.501PubMedCentralCrossRefPubMed
37.
Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, Franceschini N, van Durme YM, Chen TH, Barr RG, Schabath MB, Couper DJ, Brusselle GG, Psaty BM, van Duijn CM, Rotter JI, Uitterlinden AG, Hofman A, Punjabi NM, Rivadeneira F, Morrison AC, Enright PL, North KE, Heckbert SR, Lumley T, Stricker BH, O'Connor GT, London SJ: Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010, 42: 45-52. 10.1038/ng.500PubMedCentralCrossRefPubMed
38.
Soler Artigas M, Wain LV, Repapi E, Obeidat M, Sayers I, Burton PR, Johnson T, Zhao JH, Albrecht E, Dominiczak AF, Kerr SM, Smith BH, Cadby G, Hui J, Palmer LJ, Hingorani AD, Wannamethee SG, Whincup PH, Ebrahim S, Smith GD, Barroso I, Loos RJ, Wareham NJ, Cooper C, Dennison E, Shaheen SO, Liu JZ, Marchini J, Medical Research Council National Survey of Health and Development (NSHD) Respiratory Study Team, ahgam S, Naluai AT, Olin AC, Karrasch S, Heinrich J, Schulz H, McKeever TM, Pavord ID, Heliövaara M, Ripatti S, Surakka I, Blakey JD, Kähönen M, Britton JR, Nyberg F, Holloway JW, Lawlor DA, Morris RW, James AL, Jackson CM, Hall IP, Tobin MD, SpiroMeta Consortium: Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med 2011, 184: 786-795. 10.1164/rccm.201102-0192OCPubMedCentralCrossRefPubMed
Metadata
Title
Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children
Authors
XiWang Liu
QiXing Chen
ShanShan Shi
Zhuo Shi
Ru Lin
LinHua Tan
JianGen Yu
Qiang Shu
XiangMing Fang
Publication date
01-06-2012
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2012
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc11354

Other articles of this Issue 3/2012

Critical Care 3/2012 Go to the issue

Research

Prediction of cardiac arrest in critically ill patients presenting to the emergency department using a machine learning score incorporating heart rate variability compared with the modified early warning score

Research

Obese trauma patients are at increased risk of early hypovolemic shock: a retrospective cohort analysis of 1,084 severely injured patients

Commentary

Micronutrients against oxidative stress - time for clinical recommendations?

Review

Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection - a new frontier?

Research

The effect of earplugs during the night on the onset of delirium and sleep perception: a randomized controlled trial in intensive care patients

Review

Exercise rehabilitation following hospital discharge in survivors of critical illness: an integrative review